Efficacy and safety of type Y pegylated interferon α-2b in the treatment of patients with chronic hepatitis C virus genotypes 2/3 infection: a randomized,PegIFNα-2a-controlled phase III clinical trial

Feng Bo, Shang Jia, Wu Shuhuan, et al.

Journal of Practical Hepatology . 2017, (3): 284 -289 . DOI: 10.3969/j.issn.1672-5069.2017.03.008